Economic burden of treatment for diffuse large b-cell lymphoma
Tuesday, December 6, 2016 - 10:21
in Health & Medicine
A research team has confirmed expectations of higher healthcare utilization and costs with relapsed Diffuse Large B-Cell Lymphoma (DLBCL).